AEON Biopharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held by AEON Biopharma, Inc. on June 17, 2026. The Company is incorporated in Delaware and its Class A Common Stock trades on the NYSE American under the symbol "AEON". The filing serves to disclose the outcomes of two proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
The stockholders voted on two proposals with the following certified results:
- Proposal 1: Election of Class III Directors
- Marc Forth: Elected for a three-year term ending in 2029. Received 13,297,322 votes "For", 27,738 "Withheld", and 8,197,073 Broker Non-Votes.
- Seongsoo Park: Elected for a three-year term ending in 2029. Received 13,117,299 votes "For", 207,761 "Withheld", and 8,197,073 Broker Non-Votes.
- Proposal 2: Ratification of Independent Auditor
- KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ended December 31, 2026.
- Voting results: 21,502,418 "For", 18,217 "Against", and 1,498 "Abstain". There were no Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Verify the full text of the 2026 Proxy Statement filed on April 29, 2026, for detailed background on the director nominees and auditor ratification.
- Confirm the total number of shares outstanding and the percentage of votes cast versus total shares eligible to vote.
- Review the Company's upcoming 10-K or 10-Q filings for the fiscal year ended December 31, 2026, to obtain financial performance metrics absent from this 8-K.